Bath & Body Works (NYSE:BBWI) Releases Earnings Results, Beats Expectations By $0.05 EPS

Bath & Body Works (NYSE:BBWI) announced its quarterly earnings data on Thursday. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05, Zacks reports. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. Bath & Body Works updated its Q1 2025 guidance to 0.360-0.430 EPS and its FY 2025 guidance to 3.250-3.600 EPS.

Bath & Body Works Trading Down 10.3 %

Shares of BBWI stock traded down $4.24 on Thursday, hitting $36.85. 5,847,019 shares of the stock were exchanged, compared to its average volume of 3,541,793. The firm has a market capitalization of $7.98 billion, a P/E ratio of 8.92, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The business has a 50-day moving average of $37.82 and a 200 day moving average of $34.07.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.17%. The ex-dividend date is Friday, February 21st. Bath & Body Works’s dividend payout ratio is 19.51%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on BBWI shares. TD Cowen raised their price target on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $42.00 to $48.00 in a report on Friday, January 10th. Cowen reaffirmed a “buy” rating on shares of Bath & Body Works in a research note on Thursday. Argus reissued a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, Morgan Stanley decreased their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Six research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $44.44.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.